FDA Inspection 1102444 — Strides Pharma Private Limited

Strides Pharma Private Limited — FEI 3005151016

The FDA completed an inspection of Strides Pharma Private Limited on Aug 9, 2019 in Chengalpattu. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Aug 9, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chengalpattu (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.